Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California

Am J Public Health. 2016 Jul;106(7):1211-3. doi: 10.2105/AJPH.2016.303126. Epub 2016 Apr 14.

Abstract

Objectives: To examine changes in HIV-positive patient enrollment in a large health care delivery system before and after key Affordable Care Act (ACA) provisions went into effect in 2014.

Methods: Analyses compared HIV-positive patients newly enrolled in Kaiser Permanente Northern California between January and June 2012 (n = 339) to those newly enrolled between January and June 2014 through the California insurance exchange or via other mechanisms (n = 549).

Results: After the ACA, the HIV-positive patient enrollment increased. These new enrollees were more likely to be male (93.6% vs 89.1%; P = .01), to be enrolled in high-deductible benefit plans (≥ $1000; 18.8% vs 5.5%; P = .01), and to have better HIV viral control (HIV RNA levels below limits of quantification 79.5% vs 73.6%; P = .05) compared with pre-ACA new enrollees. Among post-ACA new enrollees, there were more patients in the lowest and highest age groups. Post-ACA exchange enrollees (22%) were more likely to be male and to have high-deductible plans than those enrolled through other mechanisms.

Conclusions: More men, higher deductibles, and better HIV viral control characterize newly enrolled HIV-positive patients after the ACA in California.

Public health implications: Evolving characteristics of HIV-positive enrollees may affect HIV policy, patient care needs, and service utilization.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Age Distribution
  • California
  • Cost Sharing
  • Female
  • HIV Infections / epidemiology*
  • Humans
  • Insurance, Health / statistics & numerical data*
  • Male
  • Middle Aged
  • Patient Protection and Affordable Care Act / statistics & numerical data*
  • RNA, Viral / blood
  • Sex Distribution
  • Socioeconomic Factors
  • United States

Substances

  • RNA, Viral